2009 - 2011 In silico drug design study targeting CRK-C3G interaction for future development of anticarcinogenic agent
2007 - 2009 In silico創薬技術を用いた新規キチナーゼ阻害剤の分子設計
2006 - 2007 3D-pharmacophore analyses of transporter ligands for drug discovery studies in consideration of pharmacokinetics
2003 - 2004 Three-dimensional structure-activity relationships of drugs induced cardiovascular side effects (prolongation in the QT interval)
2000 - 2001 Determination of binding conformations of drugs to HAS and modeling of drug-HAS complex
1998 - 1999 Analysis of binding conformations of drugs to human serum albumin (site I and site II) by NMR measurements and computational calculations
1998 - 1999 分子動力学シミュレーションによるカルモデュリン-阻害剤複合体の溶液構造解析
1996 - 1996 水溶液中の分子動力学計算に基づくα-コノトキシン類の立体構造決定
1995 - 1996 Determination of Binding Conformation of Drugs to Human Serum Albumin by Molecular Dynamics Calculations and Transferred Nuclear Overhauser Effect Measurements
Structure-based drug design
Computer-aided drug design
Study on Structure and Function of protein by Nuclear Magnetic Resonance
Show all
Papers (84):
Daichi Hayakawa, Yurie Watanabe, Hiroaki Gouda. Molecular Interaction Fields Describing Halogen Bond Formable Areas on Protein Surfaces. Journal of Chemical Information and Modeling. 2024
Tsuyoshi Saitoh, Mao Amezawa, Jumpei Horiuchi, Yasuyuki Nagumo, Naoshi Yamamoto, Noriki Kutsumura, Ryuichiro Ohshita, Akihisa Tokuda, Yoko Irukayama-Tomobe, Yasuhiro Ogawa, et al. Discovery of novel orexin receptor antagonists using a 1,3,5-trioxazatriquinane bearing multiple effective residues (TriMER) library. European journal of medicinal chemistry. 2022. 240. 114505-114505
Daichi Hayakawa, Nanako Terauchi, Aika Iwasaki, Yurie Watanabe, Hiroaki Gouda. Systematic preparation method of a molecular model explicitly describing electron distributions for halogen bonds. Chemical Physics Letters. 2022. 139754-139754
Ichiro Takasaki, Ai Watanabe, Takuya Okada, Daisuke Kanayama, Ryota Nagashima, Miyu Shudo, Ayaka Shimodaira, Kazuto Nunomura, Bangzhong Lin, Yurie Watanabe, et al. Design and synthesis of pyrido[2,3-d]pyrimidine derivatives for a novel PAC1 receptor antagonist. European Journal of Medicinal Chemistry. 2022. 231. 114160-114160
平山重人, 上之原由佳, 津村沙織, 東永華, 渡邉友里江, 合田浩明, 長瀬博, 藤井秀明. Synthesis of morphinan derivatives with an oxabicyclo[3.2.1]octane structure as dual agonists toward δ and κ opioid receptors. 日本薬学会年会要旨集(Web). 2022. 142nd
渡邉友里江, 早川大地, 合田浩明. Interaction analysis between PgDPP11 and an inhibitor NPPB using docking calculation and molecular dynamics simulation. 日本薬学会年会要旨集(Web). 2022. 142nd
早川大地, 渡邉友里江, 合田浩明. Constructions of molecular models explicitly describing electron distributions by the density fitting method. 日本薬学会年会要旨集(Web). 2022. 142nd
阪本泰光, 中村彰宏, 鈴木義之, 六本木沙織, 櫛引千里, 米澤夏里, 高橋聖人, 志田洋介, 合田浩明, 野中孝昌, et al. Structural basis for the antibacterial drug development against the multidrug-resistant strain Stenotrophomonas maltophilia DPP7. 日本薬学会年会要旨集(Web). 2022. 142nd
早川大地, 渡邉友里江, 合田浩明. Constructing and analyzing a database of HLA-antigen peptide interactions using functional spheres describing physicochemical properties. 日本薬学会年会要旨集(Web). 2021. 141st